Table 1.

Study Outcomes, Data Sources, Time Period for Assessment, and Analysis.

Outcome	Data source	Time period for assessment	Analysis
Patient experience/barriers and facilitators	Focus groups and survey	Pre- and post-intervention	Descriptive
Provider experience/barriers and facilitators	Interviews and survey	Pre- and post-intervention	Descriptive
Clinical outcomes: risk stratification, death, hospitalization, emergency department visits, home dialysis, transplantation	AKDN/ICDC data Alberta renal program data	Pre- and post-implementation of KFRE tool	Count, time-to-event, or modified Poisson models, as appropriate
Resource use: physician visits and lab tests	AKDN/ICDC data	Pre- and post-implementation of KFRE tool	Count models
Process-based quality indicators: albuminuria measure; ACE-I/ARB use and statin use	AKDN/ICDC data	Pre- and post-implementation of KFRE tool	Modified Poisson models
Costs	AKDN/ICDC data	Pre- and post-implementation of KFRE tool	Detailed costing analyses using administrative health data

Note. AKDN/ICDC = Alberta Kidney Disease Network/Interdisciplinary Chronic Disease Collaboration; KFRE = Kidney Failure Risk Equation; ACE-I/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blocker.